1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
EconMatters
insider
Articles 

Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker buys 48,833 Shares

November 16, 2012 | About:

CEO of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Mark Robert Baker buys 48,833 shares of PGNX on 11/15/2012 at an average price of $1.69 a share.

Progenics Pharmaceuticals, Inc. has a market cap of $60.1 million; its shares were traded at around $1.89 with and P/S ratio of 0.7.

This is the annual revenues and earnings per share of PGNX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PGNX.


CEO Recent Trades:



  • CEO Mark Robert Baker bought 48,833 shares of PGNX stock on 11/15/2012 at the average price of 1.69. Mark Robert Baker owns at least 93,672 shares after this. The price of the stock has increased by 11.83% since.
  • CEO Mark Robert Baker bought 1,162 shares of PGNX stock on 10/24/2012 at the average price of 2.96. Mark Robert Baker owns at least 44,839 shares after this. The price of the stock has decreased by 36.15% since.
  • CEO Mark Robert Baker bought 1,036 shares of PGNX stock on 09/26/2012 at the average price of 3.32. Mark Robert Baker owns at least 43,677 shares after this. The price of the stock has decreased by 43.07% since.
  • CEO Mark Robert Baker bought 815 shares of PGNX stock on 08/22/2012 at the average price of 4.23. Mark Robert Baker owns at least 42,641 shares after this. The price of the stock has decreased by 55.32% since.
  • CEO Mark Robert Baker bought 346 shares of PGNX stock on 07/25/2012 at the average price of 10.04. Mark Robert Baker owns at least 41,826 shares after this. The price of the stock has decreased by 81.18% since.

This is the insider trade history vs. stock price of PGNX. For the complete insider trading history of PGNX, click here.




Directors and Officers Recent Trades:



  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 07/02/2012 at the average price of 9.79. Robert J Israel owns at least 35,050 shares after this. The price of the stock has decreased by 80.69% since.
  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 06/01/2012 at the average price of 8.51. Robert J Israel owns at least 38,383 shares after this. The price of the stock has decreased by 77.79% since.


For the complete insider trading history of PGNX, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 4.0/5 (2 votes)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK